On 12/9/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 13.1%, closing at $3.89. Moreover, trading volume in this advance was above average at 145% of normal. Relative to the market the stock has been weak over the last nine months but has risen 11.1% during the last week.
Current PriceTarget Research Rating
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Marker Therapeutics has a very low Appreciation Score of 12 and a very low Power Rating of 5, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment